Jim Smith – whose concurrent roles as a Pfizer board member and Reuters CEO appear to pose a conflict of interest – serves as a board member of the World Economic Forum’s anti-corruption initiative. Smith’s leading role with the World Economic Forum’s (WEF) Partnering Against Corruption Initiative follows controversy over his position at the pharmaceutical giant and mainstream media outlet, which frequently reports on Pfizer. Reuters has published tens of thousands of articles covering or mentioning Pfizer, though the articles never disclose Smith’s affiliation with either entity. Smith serves on the board of the WEF’s Partnering Against Corruption Initiative, dubbed...
